scholarly article referring to moxduo

Spurred on by Southoz's comments, here's some more info out there on QRx's Moxduo.

The following article was published in the Annals of Palliative Medicine in July 2012. It dedicates a small section to a discussion of Moxduo and its reported ability to significantly reduce Opioid Induced Nausea/Vomiting (OINV).

http://www.amepc.org/apm/article/view/1038/1264


The article was republished in January this year in the European Journal of Pharmacology, though here it is only available to subscribers:

http://www.sciencedirect.com/science/article/pii/S0014299913007711